Photodynamic therapy cellular targets (PDT targets)

Photodynamic therapy (PDT) cellular targets refer to the specific subcellular organelles and structures where photosensitizing agents accumulate and subsequently induce cytotoxic damage upon light activation. The primary targets are typically the mitochondria, endoplasmic reticulum (ER), lysosomes, and plasma membrane, as most photosensitizers are excluded from the nucleus, thereby minimizing the risk of DNA damage and secondary malignancies (Agostinis et al., 2011, CA: A Cancer Journal for Clinicians). When the photosensitizer is exposed to light of a specific wavelength, it transfers energy to molecular oxygen, generating reactive oxygen species (ROS) like singlet oxygen. These ROS have a very short half-life and limited diffusion distance, meaning that the site of initial oxidative damage is strictly determined by the photosensitizer's localization (National Cancer Institute, 2023). Damage to the mitochondria often triggers the intrinsic apoptotic pathway via cytochrome c release, while ER damage can lead to calcium signaling disruption and autophagy. PDT is clinically utilized for the treatment of various solid tumors, dermatological conditions such as actinic keratosis, and ophthalmological diseases like age-related macular degeneration.

Other names

Subcellular photosensitizer targetsPDT-sensitive organellesCellular targets of photodynamic therapyPhotosensitizer localization sites

Generation of reactive oxygen species (ROS), primarily singlet oxygen, upon light activation of a localized photosensitizer, leading to oxidative damage of lipids and proteins within specific organelles (Mroz et al., 2011, Cancers).